| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/07/2007 | CN1923797A Pharmaceutical compounds |
| 03/07/2007 | CN1923262A Exterior-applied Chinese medicine for treating facial palsy |
| 03/07/2007 | CN1923241A Medicine composition containing epimedium extract, uncaria extract, and gastrodine, and its preparation and use |
| 03/07/2007 | CN1923231A Nose-plug medicine for treating hemicrania and its preparing process |
| 03/07/2007 | CN1923195A Application of cumarin kind compound in preparation of medicine for inducing nerve stem cell orienting differentiation |
| 03/07/2007 | CN1923185A Gastrodine tablets disintegrating in oral cavity and process for producing same |
| 03/07/2007 | CN1923184A Multiple apertures releasing osmosis pump and preparation process thereof |
| 03/07/2007 | CN1303098C Pseudo portulaca oleracea saponin compound, total sapon in and its application in medicine |
| 03/07/2007 | CN1303097C Japanese polygala saponin kind compound and aglucon, total saponin and total aglucon and its application in medicine |
| 03/07/2007 | CN1303085C C6- and C9-substituted isoxazoline derivatives and their use as anti-depressants |
| 03/07/2007 | CN1303072C 7-oxo pyridopyrimidines |
| 03/07/2007 | CN1303069C Acutumine and acutumine compound, synthesis and use thereof |
| 03/07/2007 | CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/07/2007 | CN1303066C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 03/07/2007 | CN1303059C Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 03/07/2007 | CN1302811C Externally-applicated chewing gum including chip-like center |
| 03/07/2007 | CN1302795C Drug-dropping medicine and its preparing method |
| 03/07/2007 | CN1302792C Medicine composition with the action of relieving alcoholism and protecting liver and its application |
| 03/07/2007 | CN1302789C Medicinal cigarettes against drug addiction and preparing method thereof |
| 03/07/2007 | CN1302772C Orally disintegrated sodium ferulate tablet and its prepn process |
| 03/07/2007 | CN1302771C 2-(4-isobutylphenyl) propionic acid medicinal composition |
| 03/06/2007 | US7186870 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 03/06/2007 | US7186864 Trifluoromethyl-substituted nitrogen compounds; treating type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumors, and glaucoma |
| 03/06/2007 | US7186859 Uses for amino acid anticonvulsants |
| 03/06/2007 | US7186840 Quinoline derivatives as anti-inflammatory agents |
| 03/06/2007 | US7186836 Thienyl compounds |
| 03/06/2007 | US7186826 Phosphorus-containing compounds and uses thereof |
| 03/06/2007 | US7186825 Polyamines for treatment of diseases such as cancer or treatment of tumors |
| 03/06/2007 | US7186803 Human vanilloid receptor VR3 protein |
| 03/06/2007 | US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents |
| 03/06/2007 | US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 03/06/2007 | US7186748 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 03/06/2007 | US7186743 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics |
| 03/06/2007 | US7186741 Neurotensin active 2,3,diaryl-pyrazolidine derivatives |
| 03/06/2007 | US7186737 Inhibitors of p38 |
| 03/06/2007 | US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders |
| 03/06/2007 | US7186733 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
| 03/06/2007 | US7186720 Moderator of tumor necrosis factor; antiinflammatory agents; autoimmune diseases |
| 03/06/2007 | US7186717 Pyrrolidine derivatives as Factor Xa inhibitors |
| 03/06/2007 | US7186711 Can be administered orally or parenterally, in small intervals until an effective dose is achieved |
| 03/06/2007 | US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders |
| 03/06/2007 | US7186708 Steroidal compounds |
| 03/06/2007 | US7186703 Derivatives of branched-chain lipophilic molecules and uses thereof |
| 03/06/2007 | US7186407 Including claudication and critical limb ischemia, by administering fibroblast growth factor (FGF) in two doses, a single dose administered into each leg of the patient within one hour |
| 03/06/2007 | CA2389264C Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 03/06/2007 | CA2382405C New processes for synthesizing (3as)-5,5-dioxo-2,3,3a,4-tetrahydro-1h-pyrrolo[2,1-c][1,2,4]benzothiadiazine |
| 03/06/2007 | CA2294990C Pharmaceutical compositions and methods for effecting dopamine release |
| 03/06/2007 | CA2263961C Cocaine receptor binding ligands |
| 03/06/2007 | CA2191677C Cerebral function improving agents |
| 03/06/2007 | CA2189131C Use of pteridine derivatives as no-synthase inhibitors |
| 03/06/2007 | CA2186243C Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity |
| 03/06/2007 | CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/01/2007 | WO2007025306A1 Transplantation of glial restricted precursor-derived astrocytes for promotion of axon growth |
| 03/01/2007 | WO2007025249A2 Methods for treatment of headaches by administration of oxytocin |
| 03/01/2007 | WO2007025177A2 Neurogenesis by muscarinic receptor modulation |
| 03/01/2007 | WO2007025144A1 5-ht2c receptor agonists as anorectic agents |
| 03/01/2007 | WO2007025055A2 Benztropine compounds and uses thereof as dopamine uptake inhibitors |
| 03/01/2007 | WO2007024846A2 Anit-il-23 antibiodies |
| 03/01/2007 | WO2007024814A1 HETEROARYL-SUBSTiTUTED DIAZATRICYCLOALKANES, METHODS FOR ITS PREPARATION AND USE THEREOF |
| 03/01/2007 | WO2007024789A1 Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use |
| 03/01/2007 | WO2007024593A1 Fused tricyclic mglur1 antagonists as therapeutic agents |
| 03/01/2007 | WO2007024008A1 Preventive or therapeutic agent for side effect based on cytotoxicity of anticancer therapy containing apoptosis inhibition activity-enhancing protein fnk or nucleic acid encoding the same |
| 03/01/2007 | WO2007024004A1 Phenylpyridone derivative |
| 03/01/2007 | WO2007023880A1 Chemokine production inhibitor |
| 03/01/2007 | WO2007023479A2 Treatment of central nervous system injury |
| 03/01/2007 | WO2007023290A1 Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors |
| 03/01/2007 | WO2007023242A1 Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors |
| 03/01/2007 | WO2007023141A1 N-oxides as prodrugs of piperazine & piperidine derivatives |
| 03/01/2007 | WO2007023114A1 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | WO2007022999A1 Polymer conjugates of k-252a and derivatives thereof |
| 03/01/2007 | WO2007022991A1 Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis in ischemia or after ischemic episode in the brain |
| 03/01/2007 | WO2007022947A2 5-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptors |
| 03/01/2007 | WO2007022946A1 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors |
| 03/01/2007 | WO2007022936A1 Triazolyl derivatives of azabicyclo [3.1.0] hexane as dopamine d3 receptor modulators |
| 03/01/2007 | WO2007022935A1 Azabicyclo [3.1.0] hexylphenyl derivatives as modulators of dopamine d3 receptors |
| 03/01/2007 | WO2007022933A1 Triazole derivatives as modulators of dopamine d3 receptors |
| 03/01/2007 | WO2007022734A1 A composition for alleviating a hangover comprising hyaluronic acid and activated carbon |
| 03/01/2007 | WO2007022710A1 Chinese medicinal compositions for treating headache, formulations and processes for preparation thereof |
| 03/01/2007 | WO2006138510B1 Substituted enaminones as nicotinic acetylcholine receptor modulators |
| 03/01/2007 | WO2006138265A3 Heterocyclic aspartyl protease inhibitors, preparation and use thereof |
| 03/01/2007 | WO2006138264A3 Aspartyl protease inhibitors |
| 03/01/2007 | WO2006124897A3 Methods and compositions for improving cognition |
| 03/01/2007 | WO2006124748A3 Multicyclic compounds and methods of their use |
| 03/01/2007 | WO2006122186A3 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia |
| 03/01/2007 | WO2006117700A3 Process for preparing quetiapine and quetiapine fumarate |
| 03/01/2007 | WO2006108151A9 Crystalline forms of pregabalin |
| 03/01/2007 | WO2006103546A3 Treatment of parkinson's disease, obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine h3-receptor ligands |
| 03/01/2007 | WO2006102644A3 Methods for the treatment of central nervous system injury via a tapered administration of progesterone |
| 03/01/2007 | WO2006073265A9 Composition comprising an extract of gramineae plant for the prevention and treatment of ischemic diseases and degenerative brain diseases and the use thereof |
| 03/01/2007 | WO2006056783A3 Structured phospholipids for treating autoimmune and neurodegenerative diseases |
| 03/01/2007 | WO2006042249A3 Methods and compositions for treating migraine pain |
| 03/01/2007 | WO2004100939B1 Combination of the analeptic modafinil and an antidepressant for the treatment of depression |
| 03/01/2007 | US20070049735 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070049620 Cyclic tertiary amine compound |
| 03/01/2007 | US20070049607 Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists |
| 03/01/2007 | US20070049600 Pteridinones as kinase inhibitors |
| 03/01/2007 | US20070049594 Novel compounds and compositions as cathepsin inhibitors |
| 03/01/2007 | US20070049583 Benzoxazine and benzothiazine derivatives and their use in pharmaceutical agents |